KRYS

Krystal Biotech

• The Motley Fool·1d ago

  These 3 Healthcare Stocks Have Crushed the Market This Year. Here's Why There's More Upside Ahead

• PUBT·2d ago

  Krystal Biotech updates financial calendar with quarterly results release, conference call

• NASDAQ·2d ago

  Notable ETF Outflow Detected - IWO, FROG, GKOS, KRYS

• Simply Wall St·3d ago

  Is A Single-Patient KB801 Outcome Quietly Reframing Krystal Biotech's Clinical Narrative (KRYS)?

• Simply Wall St·4d ago

  Is Krystal Biotech (KRYS) Overvalued On Its KB801 Patent Data Update?

• TipRanks·4d ago

  Krystal Biotech Updates KB801 Patent Office Filing

• Benzinga·4d ago

  Krystal Biotech Files Response With USPTO on KB801 Patent Application; Discontinues Clinical Study To Advance KB801 Into Pivotal Trial; No Safety Concerns Observed; No Further Subject-level Updates From Discontinued Study; Pivotal Trial Results Expected In Due Course

• Reuters·4d ago

  KRYSTAL BIOTECH - NO FURTHER SUBJECT-LEVEL UPDATES FROM DISCONTINUED STUDY; PIVOTAL TRIAL RESULTS EXPECTED IN DUE COURSE - SEC FILING

• Reuters·4d ago

  BUZZ-Construction firm Tutor Perini jumps on S&P SmallCap inclusion

• Seeking Alpha·5d ago

  Krystal Biotech joins the S&P MidCap 400 as TMHC and AVNS exit indexes

• TipRanks·5d ago

  Krystal Biotech to replace Taylor Morrison in S&P 400 at open on 7/24

• TipRanks·5d ago

  Tutor Perini to replace Krystal Biotech in S&P 600 at open on 7/24

• Benzinga·5d ago

  Krystal Biotech To Replace Taylor Morrison Home In The S&P MidCap 400, And Tutor Perini To Replace Krystal Biotech In The S&P SmallCap 600 Effective Prior To The Opening Of Trading On Friday, July 24

• Reuters·5d ago

  S&P DOW JONES INDICES SAYS KRYSTAL BIOTECH INC. WILL REPLACE TAYLOR MORRISON HOME CORP. IN THE S&P MIDCAP 400